Chiropractic care for hypertension: Review of the literature and study of biological and genetic bases

Main Article Content

Stephanie GB Sullivan
Stefano Paolacci
Aysha Karim Kiani
Matteo Bertelli


Hypertension, autonomic nervous system, spinal manipulative therapy, chiropractic manipulative therapy, sympathetic response, parasympathetic response


Background and aim: Hypertension is a multifactorial condition that is among the leading causes of mortality worldwide. Regulation of blood pressure greatly depends upon the activity of the autonomic nervous system. Alterations in the autonomic nervous system can lead to hypertension. In addition to nervous system control and individual physiologic state, various genes can directly influence autonomic responses. The complexity of blood pressure control is reflected in the 20-30% of individuals resistant to traditional pharmacological treatment, this indicates the need for alternative interventions. This article provides an integrative review and discussion of the key neurophysiologic and genetic factors that contribute to blood pressure regulation, the autonomic nervous system (ANS) and manual therapy literature, and the manual therapy and blood pressure literature. Methods: To assess the effects of chiropractic on the management of hypertension we searched articles published from 1980 to 2019 in PubMed, the Index to Chiropractic Literature and CINAHL, using the keywords: chiropractic, spinal manipulation, hypertension, and blood pressure. Results: We found 38 original studies that analyzed the effect of chiropractic therapy on hypertension. Of these studies, 10 were case reports and the statistical significance of the effects of chiropractic on blood pressure was not evaluated on these articles, so we focused on the remaining 28 articles. Conclusions: The results of the review relative to chiropractic care were promising, but often contradictory, suggesting more research should be done. In consideration of the complexity of ANS blood pressure control, an evaluation of patient presenting physiologic and genetic characteristics is recommended and could provide valuable insight relative to the likelihood of patient blood pressure related responsiveness to care


Download data is not yet available.


Metrics Loading ...
Abstract 102 | PDF Downloads 60


1. Petkovich BW, Vega J, Thomas S. Vagal modulation of hypertension. Curr Hypertens Rep 2015; 17: 532.
2. National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda (MD), US: National Heart, Lung, and Blood Institute, 2004: 04-5230.
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365: 217-23.
4. Dickson ME, Sigmund CD. Genetic basis of hypertension: Revisiting angiotensinogen. Hypertension 2006; 48: 14-20.
5. Bolívar JJ. Essential hypertension: An approach to its etiology and neurogenic pathophysiology. Int J Hypertens 2013; 2013: 547809.
6. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23: 1052-60.
7. Okutucu S, Karakulak UN, Kabakçi G. Circadian blood pressure pattern and cardiac autonomic functions: Different aspects of same pathophysiology. Anadolu Kardiyol Derg 2011; 11: 168-73.
8. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects: Evaluation by power spectral analysis of heart rate variability. Hypertension 1995; 26: 808-14.
9. Grassi G, Pisano A, Bolignano D, et al. Sympathetic nerve traffic activation in esssential hypertension and its correlates: Systematic reviews and meta-analyses. Hypertension 2018; 72: 483-91.
10. Grassi G, Seravalle G, Quarti-Trevano F. The “neuroadrenergic hypothesis” in hypertension: Current evidence. Exp Physiol 2010; 95: 581-6.
11. Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res 2015; 116: 976-90.
12. Notay K, Klingel SL, Lee JB, et al. TRPV1 and BDKRB2 receptor polymorphisms can influence the exercise pressor reflex. J Physiol 2018; 596: 5135-48.
13. Krushkal J, Ferrell R, Mockrin SC, Turner ST, Sing CF, Boerwinkle E. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 1999; 99: 1407-10.
14. Grassi G, Ram VS. Evidence for a critical role of the sympathetic nervous system in hypertension. J Am Soc Hypertens 2016; 10: 457-66.
15. Braam B, Taler SJ, Rahman M, et al. Recognition and management of resistant hypertension. Clin J Am Soc Nephrol 2017; 12: 524-35.
16. Handley A, Lloyd E, Roberts A, Barger B. Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: A one-year, phase 3, open-label study. Clin Exp Hypertens 2016; 38: 180-8.
17. Jung HW, Kim KI, Park CG, et al. A multicenter, non-comparative study to evaluate the efficacy and safety of fixed-dose olmesartan/amlodipine in Korean patients with hypertension who are naïve or non-responders to anti-hypertensive monotherapy (ACE-HY study). Clin Exp Hypertens 2015; 37: 482-9.
18. Rakugi H, Tsuchihashi T, Shimada K, et al. Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension. Clin Exp Hypertens 2015; 37: 260-6.
19. Doroszko A, Janus A, Szahidewicz-Krupska E, Mazur G, Derkacz A. Resistant hypertension. Adv Clin Exp Med 2016; 25: 173-83.
20. Calhoun D, Schiffrin E, Flack J. Resistant hypertension: An update. Am J Hypertens 2019; 32: 1-3.
21. Weitzman D, Chodick G, Shalev V, Grossman C, Grossman E. Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel. Hypertension 2014; 64: 501-7.
22. Yaxley J, Thambar S. Resistant hypertension: An approach to management in primary care. J Fam Med Prim Care 2015; 4: 193-9.
23. Yates RG, Lamping DL, Abram NL, Wright C. Effects of chiropractic treatment on blood pressure and anxiety: A randomized, controlled trial. J Manipulative Physiol Ther 1988; 11: 484-8.
24. Amoroso Borges BL, Bortolazzo GL, Neto HP. Effects of spinal manipulation myofascial techniques on heart rate variability: A systematic review. J Bodyw Mov Ther 2018; 22: 203-8.
25. Bolton PS, Budgell B. Visceral responses to spinal manipulation. J Electromyogr Kinesiol 2012; 22: 777-84.
26. Bronfort G, Haas M, Evans R, Leininger B, Triano J. Effectiveness of manual therapies: The UK evidence report. Chiropr & Osteopat 2010; 18: 3.
27. Mangum K, Partna L, Vavrek D. Spinal manipulation for the treatment of hypertension: A systematic qualitative literature review. J Manipulative Physiol Ther 2012; 35: 235-43.
28. McKnight ME, DeBoer KF. Preliminary study of blood pressure changes in normotensive subjects undergoing chiropractic care. J Manipulative Physiol Ther 1988; 11: 261-6.
29. McMasters KL, Wang J, York J, Hart J, Neely C, Delain RJ. Blood pressure changes in African American patients receiving chiropractic care in a teaching clinic: A preliminary study. J Chiropr Med 2013; 12: 55-9.
30. Mancia G, Grassi G. The autonomic nervous system and hypertension. Circ Res 2014; 114: 1804-14.
31. Armstrong M, Moore RA. Physiology, baroreceptors. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2019.
32. Fountain JH, Lappin SL. Physiology, renin angiotensin system. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2018.
33. Patil SJ, Wareg NK, Hodges KL, Smith JB, Kaiser MS, LeFevre ML. Home blood pressure monitoring in cases of clinical uncertainty to differentiate appropriate inaction from therapeutic inertia. Ann Fam Med 2020; 18: 50-8.
34. Schnaubelt S, Hammer A, Koller L, et al. Expert opinion: Meditation and cardiovascular health: What is the link? Eur Cardiol 2019; 14: 161-4.
35. Mancia G. Short- and long-term blood pressure variability: Present and future. Hypertension 2012; 60: 512-7.
36. Mark AL. The sympathetic nervous system in hypertension: A potential long-term regulator of arterial pressure. J Hypertens Suppl 1996; 14: S159-65.
37. Grassi G, Pisano A, Bolignano D, et al. Sympathetic nerve traffic activation in essential hypertension and its correlates: systematic reviews and meta-analyses. Hypertension 2018; 72: 483-91.
38. Oparil S, Acelajado MC, Bakris GL, et al. Hypertension. Nat Rev Dis Prim 2018; 4: 18014.
39. Julius S. Autonomic nervous system dysregulation in human hypertension. Am J Cardiol 1991; 67: 3B-7B.
40. Ernst G. Heart-rate variability—More than heart beats? Front Public Heal 2017; 5: 240.
41. Fisher JP, Paton JFR. The sympathetic nervous system and blood pressure in humans: Implications for hypertension. J Hum Hypertens 2012; 26: 463-75.
42. Albaghdadi M. Baroreflex control of long-term arterial pressure. Rev Bras Hipertens 2007; 14: 212-25.
43. Jordan J, Biaggioni I. Genetic influences on human baroreflex regulation. Auton Neurosci Basic Clin 2012; 172: 23-5.
44. Shahoud JS, Aeddula NR. Physiology, arterial pressure regulation. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2019.
45. Andani R, Khan YS. Anatomy, head and neck, carotid sinus. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2020.
46. Robertson D, Hollister AS, Biaggioni I, Netterville JL, Mosqueda-Garci R, Robertson RM. The diagnosis and treatment of baroreflex failure. N Engl J Med 1993; 329: 1449-55.
47. Smit AAJ, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol 1999; 519: 1-10.
48. Hirooka Y. Importance of neural arc for baroreflex resetting in hypertension. Circ J 2015; 79: 510-2.
49. Hirooka Y, Kishi T, Ito K, Sunagawa K. Potential clinical application of recently discovered brain mechanisms involved in hypertension. Hypertension 2013; 62: 995-1002.
50. Nishikino M, Matsunaga T, Yasuda K, et al. Genetic variation in the renin-angiotensin system and autonomic nervous system function in young healthy Japanese subjects. J Clin Endocrinol Metab 2006; 91: 4676-81.
51. MacFadyen RJ, Lees KR, Reid JL. Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs. Br J Clin Pharmacol 1991; 31: 1-13.
52. Lees KR, MacFadyen RJ, Reid JL. Tissue angiotensin converting enzyme inhibition: relevant to clinical practice? Am J Hypertens 1990; 3: 266S-72S.
53. Macfadyen RJ, Lees KR, Reid JL. Perindopril. A review of its pharmacokinetics and clinical pharmacology. Drugs 1990; 39: 49-63.
54. Said SI. Metabolic functions of the pulmonary circulation. Circ Res 1982; 50: 325-33.
55. Scott JH, Dunn RJ. Physiology, aldosterone. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2019.
56. McKinley MJ, McAllen RM, Pennington GL, Smardencas A, Weisinger RS, Oldfield BJ. Physiological actions of angiotensin II mediated by AT1 and AT2 receptors in the brain. Clin Exp Pharmacol Physiol 1996; 23: S99-104.
57. Warren JH, Lewis W, Wraa CE, Stebbins CL. Central and peripheral effects of angiotensin II on the cardiovascular response to exercise. J Cardiovasc Pharmacol 2001; 38: 693-705.
58. Delong C, Sharma S. Physiology, peripheral vascular resistance. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2019.
59. Okamura K, Yano Y, Takamiya Y, Shirai K, Urata H. Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): “Issues with hypertension studies in real-world practice.” Clin Exp Hypertens 2019: 1-11.
60. LiverTox: Clinical and Research Information on Drug- Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2018.
61. Llorens-Cortes C, Touyz RM. Evolution of a new class of antihypertensive drugs: targeting the brain renin-angiotensin system. Hypertens (Dallas, Tex 1979) 2020; 75: 6-15.
62. Welch A, Boone R. Sympathetic and parasympathetic responses to specific diversified adjustments to chiropractic vertebral subluxations of the cervical and thoracic spine. J Chiropr Med 2008; 7: 86-93.
63. Xu X, Ding X, Zhang X, et al. Genetic and environmental influences on blood pressure variability: A study in twins. J Hypertens 2013; 31: 690-7.
64. Freitas SR, Pereira AC, Floriano MS, Mill JG, Krieger JE. Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population. BMC Cardiovasc Disord 2008; 8: 40.
65. Chitbangonsyn SW, Mahboubi P, Walker D, et al. Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: A somatic cell radiation hybrid library approach. J Hum Hypertens 2003; 17: 319-24.
66. Abe M, Wu Z, Yamamoto M, et al. Association of dopamine β-hydroxylase polymorphism with hypertension through interaction with fasting plasma glucose in Japanese. Hypertens Res 2005; 28: 215-21.
67. Rao F, Zhang L, Wessel J, et al. Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: Discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 2007; 116: 993-1006.
68. Rao F, Zhang L, Wessel J, et al. Adrenergic polymorphism and the human stress response. Ann NY Acad Sci 2008; 1148: 282-96.
69. Chen Y, Zhang K, Wen G, et al. Human dopamine β-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure. Am J Hypertens 2011; 24: 24-32.
70. Jacob JJ, Lindpaintner K, Lincoln SE, et al. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 1991; 67: 213-24.
71. Huang C, Zhang S, Hu K, Ma Q, Yang T. Phenylethanolamine N-methyltransferase gene promoter haplotypes and risk of essential hypertension. Am J Hypertens 2011; 24: 1222-6.
72. Bojic T, Milovanovic B, Cupic SJ. Genetic polymorphisms of neurocardiovascular disorders. Arch Med 2015; 7: 1-22.
73. Zhang L, Rao F, Zhang K, et al. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. J Clin Invest 2007; 117: 2658-71.
74. Yasuda K, Matsunaga T, Moritani T, et al. T393C polymorphism of GNAS1 associated with the autonomic nervous system in young, healthy Japanese subjects. Clin Exp Pharmacol Physiol 2004; 31: 597-601.
75. Cabadak H, Orun O, Nacar C, et al. The role of G protein β3 subunit polymorphisms C825T, C1429T, and G5177A in Turkish subjects with essential hypertension. Clin Exp Hypertens 2011; 33: 202-8.
76. Milan A, Mulatero P, Williams TA, et al. Bradykinin B2 receptor gene (-58T/C) polymorphism influences baroreflex sensitivity in never-treated hypertensive patients. J Hypertens 2005; 23: 63-9.
77. Budgell BS. Reflex effects of subluxation: The autonomic nervous system. J Manipulative Physiol Ther 2000; 23: 104-6.
78. Chiu TW, Wright A. To compare the effects of different rates of application of a cervical mobilisation technique on sympathetic outflow to the upper limb in normal subjects. Man Ther 1996; 1: 198-203.
79. Browning KN, Verheijden S, Boeckxstaens GE. The vagus nerve in appetite regulation, mood, and intestinal inflammation. Gastroenterology 2017; 152: 730-44.
80. Waxenbaum JA, Varacallo M. Anatomy, autonomic nervous system. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2020.
81. Tindle J, Tadi P. Neuroanatomy, parasympathetic nervous system. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2020.
82. Ranson SW. Anatomy of the sympathetic nervous system: with reference to sympathectomy and ramisection. JAMA 1926; 86: 1886–90.
83. Janig W, Habler HJ. Neurophysiological analysis of target-related sympathetic pathways - From animal to human: Similarities and differences. Acta Physiol Scand 2003; 177: 255-74.
84. Benedek M, Kaernbach C. A continuous measure of phasic electrodermal activity. J Neurosci Methods 2010; 190: 80-91.
85. Chu J, Allen DD, Pawlowsky, Smoot B. Peripheral response to cervical or thoracic spinal manual therapy: An evidence-based review with meta-analysis. J Manipulative Physiol Ther 2014; 22: 220-9.
86. Vicenzino B, Collins D, Benson H, Wright A. An investigation of the interrelationship between manipulative therapy-induced hypoalgesia and sympathoexcitation. J Manipulative Physiol Ther 1998; 21: 448-53.
87. La Touche R, Paris-Alemany A, Mannheimer JS, et al. Does mobilization of the upper cervical spine affect pain sensitivity and autonomic nervous system function in patients with cervico-craniofacial pain? A randomized-controlled trial. Clin J Pain 2013; 29: 205-15.
88. Bakris G, Dickholtz M, Meyer PM, et al. Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: A pilot study. J Hum Hypertens 2007; 21: 347-52.
89. Driscoll MD, Hall MJ. Effects of spinal manipulative therapy on autonomic activity and the cardiovascular system: A case study using the electrocardiogram and arterial tonometry. J Manipulative Physiol Ther 2000; 23: 545-50.
90. Torns S. Atlas vertebra realignment and arterial blood pressure regulation in 42 subjects. J Upper Cervical Chiropr Res 2012: 40-45.
91. Torns S. Reduction in arterial blood pressure following adjustment of atlas to correct vertebral subluxation: A prospective longitudinal cohort study. J Upper Cervical Chiropr Res 2014: 54-60.
92. Ward J, Tyer K, Coats J, Williams G, Weigand S, Cockburn D. Immediate effects of atlas manipulation on cardiovascular physiology. Clin Chiropr 2012; 15: 147-57.
93. Hannah JS. Changes in systolic and diastolic blood pressure for a hypotensive patient receiving upper cervical specific: A case report. Chiropr J Aust 2009; 39: 118-21.
94. Knutson GA. Significant changes in systolic blood pressure post vectored upper cervical adjustment vs resting control groups: A possible effect of the cervicosympathetic and/or pressor reflex. J Manipulative Physiol Ther 2001; 24: 101-9.
95. Kessinger R, Qualls T, Hart J, et al. Pulse pressure findings following upper cervical care: A practice-based observational study. J Can Chiropr Assoc 2019; 63: 51-8.
96. Plaugher G, Bachman TR. Chiropractic management of a hypertensive patient. J Manipulative Physiol Ther 1993; 16: 544-9.
97. Plaugher G, Long CR, Alcantara J, et al. Practice-based randomized controlled-comparison clinical trial of chiropractic adjustments and brief massage treatment at sites of subluxation in subjects with essential hypertension: Pilot study. J Manipulative Physiol Ther 2002; 25: 221-39.
98. Prater-Manor S, Clifton E, York A. Resolution of anxiety and hypertension in a 60-year old male following subluxation based chiropractic care: A case study and review of the literature. Ann Vert Sublux Res 2015: 146-53.
99. Roffers S, Huber L, Morris D, Stiles A, Barton D, House T. A randomized controlled trial to measure the effects of specific thoracic chiropractic adjustments on blood pressure and pulse rate. Clin Chiropr 2011; 14: 169-70.
100. Roffers S, Stiles A, Huber L, Morris D, Barton D, House T. Measuring the effects of specific cervical chiropractic adjustments on blood pressure and pulse rate: A randomized controlled trial. Clin Chiropr 2011; 4: 170.
101. Qualls T, Lester C. Resolution of atrial fibrillation & hypertension in a patient undergoing upper-cervical chiropractic care. J Upper Cervical Chiropr Res 2012: 9-15.
102. Whedon E. Upper cervical specific chiropractic management of a patient with hypertension: A case report and selective review of the literature. J Upper Cervical Chiropr Res 2013: 1-13.
103. Kessinger R, Moe C. Improvement in chronic hypertension following a single upper cervical adjustment: A case report. J Upper Cervical Chiropr Res 2015: 1-5.
104. Schwartzbauer J, Kolber J, Schwartzbauer M, Hart J, Zhang J. Athletic performance and physiological measures in baseball players following upper cervical chiropractic care: A pilot study. J Vert Sublux Res 1997; 1: 1.
105. Scott RM, Kaufman CL, Dengel DR. The impact of chiropractic adjustments on intracranial blood flow: A pilot study. J Vert Sublux Res 2007: 1-8.
106. Chung J, Brown J, Busa J. Resolution of hypertension following reduction of upper cervical vertebral subluxation: A case study. J Upr Cerv Chiropr Res 2014; 1: 1-6.
107. Goertz CM, Salsbury SA, Vining RD, et al. Effect of spinal manipulation of upper cervical vertebrae on blood pressure: results of a pilot sham-controlled trial. J Manipulative Physiol Ther 2016; 39: 369-80.
108. Goertz CH, Grimm RH, Svendsen K, Grandits G. Treatment of hypertension with alternative therapies (THAT) study: A randomized clinical trial. J Hypertens 2002; 20: 2063-8.
109. Holt K, Beck R, Sexton S, Taylor HH. Reflex effects of a spinal adjustment on blood pressure. Chiropr Aust 2010; 40: 95.
110. Morgan JP, Dickey J, Hunt H, Hudgins P. A controlled trial of spinal manipulation in the management of hypertension. J Am Osteopath Assoc 1985; 85: 308-13.
111. Win NN, Jorgensen AMS, Chen YS, Haneline MT. Effects of upper and lower cervical spinal manipulative therapy on blood pressure and heart rate variability in volunteers and patients with neck pain: A randomized controlled, cross-over, preliminary study. J Chiropr Med 2015; 14: 1-9.
112. Nansel D, Jansen R, Cremata E, Dhami M, Holley D. Effects of cervical adjustments on lateral-flexion passive end-range asymmetry and on blood pressure, heart rate and plasma catecholamine levels. J Manipulative Physiol Ther 1991; 14: 450-6.
113. Van Dyke V, Russell D, Alcantar J. Resolution of hypertension in a 72-year-old male following subluxation based chiropractic care: A case report and selective review of the literature. Ann Vert Sublux Res 2015: 172-6.
114. Vansen Z. Reduction of blood pressure in a patient receiving chiropractic care: A case study & review of literature. Annals of Vert Sublux Res 2017; 2017: 15-33.
115. Wickes D. Effects of thoracolumbar spinal manipulation on arterial flow in the lower extremity. J Manipulative Physiol Ther 1980; 3: 3-6.
116. Younes M, Nowakowski K, Didier-Laurent B, Gombert M, Cottin F. Effect of spinal manipulative treatment on cardiovascular autonomic control in patients with acute low back pain. Chiropr & Manual Ther 2017; 25: 33.
117. Ward J, Coats J, Tyer K, Weigand S, Williams G. Immediate effects of anterior upper thoracic spine manipulation on cardiovascular response. J Manipulative Physiol Ther 2013; 36: 101-10.
118. Ward J, Tyer K, Coats J, Williams G, Kulcak K. Immediate effects of upper thoracic spine manipulation on hypertensive individuals. J Manipulative Physiol Ther 2015; 23: 43-50.
119. Watanabe N, Polus BI. A single mechanical impulse to the neck: Does it influence autonomic regulation of cardiovascular function? Chiropr J Aust 2007; 37: 42.
120. Dimmick KR, Young MF, Newell D. Chiropractic manipulation affects the difference between arterial systolic blood pressures on the left and right in normotensive subjects. J Manipulative Physiol Ther 2006; 29: 46-50.
121. Budgell B, Hirano F. Innocuous mechanical stimulation of the neck and alterations in heart-rate variability in healthy young adults. Auton Neurosci 2001; 91: 96-9.
122. Goncalves G, Le Scanff C, Leboeuf-Yde C. Effect of chiropractic treatment on primary or early secondary prevention: A systematic review with a pedagogic approach. Chiropr Man Ther 2018; 26: 10.

Most read articles by the same author(s)

1 2 > >>